Evaluation of the editing process in human immunodeficiency virus type 1 genotyping

Journal of Clinical Microbiology

Volumn 41, Issue 7, 2003, Pages 3265-3272

  Huang, Diana D ^a   Eshleman, Susan H ^b   Brambilla, Donald J ^c   Palumbo, Paul E ^d   Bremer, James W ^a  

^a RUSH MEDICAL COLLEGE   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

^c NEW ENGLAND RESEARCH INSTITUTES   (United States)

^d RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PRIMER DNA; PRIMER RNA; PROTEINASE; RNA DIRECTED DNA POLYMERASE;

ANALYSIS; ARTICLE; CODON; COMPARATIVE STUDY; COMPUTER PROGRAM; CONSENSUS SEQUENCE; EVALUATION; GENE MUTATION; GENE SEQUENCE; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; LABORATORY; NORMAL HUMAN; PRIORITY JOURNAL; QUESTIONNAIRE; RESEARCH; RNA EDITING; SAMPLE; SEQUENCE ANALYSIS; SEQUENCE DATABASE; VIRUS MUTATION; VIRUS RESISTANCE;

ANTI-HIV AGENTS; BASE SEQUENCE; CONSENSUS SEQUENCE; DATA INTERPRETATION, STATISTICAL; DRUG RESISTANCE, VIRAL; GENOTYPE; HIV PROTEASE; HIV-1; HIV-1 REVERSE TRANSCRIPTASE; HUMANS; LABORATORIES; MICROBIAL SENSITIVITY TESTS; MUTATION; OBSERVER VARIATION; QUALITY CONTROL; QUESTIONNAIRES; SEQUENCE ANALYSIS, DNA;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0037830320     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.41.7.3265-3272.2003     Document Type: Article

References (13)

1. Arens, M. 2001. Clinically relevant sequence-based genotyping of HBV, HCV, CMV, and HIV. J. Clin. Virol. 22:11-29.
2. Baxter, J. D., D. L. Mayers, D. N. Wentworth, J. D. Neaton, M. L. Hoover, M. A. Winters, S. B. Mannheimer, M. A. Thompson, D. I. Abrams, B. J. Brizz, J. P. Ioannidis, T. C. Merigan, et al. 2000. A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy. AIDS 14:F83-F93.
3. Clevenbergh, P., J. Durant, P. Halfon, P. del Giudice, V. Mondain, N. Montagne, J. M. Schapiro, C. A. Boucher, and P. Dellamonica. 2000. Persisting long-term benefit of genotype-guided treatment for HIV-infected patients failing HAART. The Viradapt Study: week 48 follow-up. Antiviral Ther. 5:65-70.
4. DeGruttola, V., L. Dix, R. D'Aquila, D. Holder, A. Phillips, M. Ait-Khaled, J. Baxter, P. Clevenbergh, S. Hammer, R. Harrigan, D. Katzenstein, R. Lanier, M. Miller, M. Para, S. Yerly, A. Zolopa, J. Murray, A. Patick, V. Miller, S. Castillo, L. Pedneault, and J. Mellors, 2000. The relation between baseline HIV drug resistance and response to antiretroviral therapy: reanalysis of retrospective and prospective studies using a standardized data analysis plan. Antiviral Ther. 5:41-48.
5. Erali, M., S. Page, L. G. Reimer, and D. R. Hillyard. 2001. Human immunodeficiency virus type 1 drug resistance testing: a comparison of three sequence-based methods. J. Clin. Microbiol. 39:2157-2165.
6. Hanna, G. J., and R. T. D'Aquila. 2001. Clinical use of genotypic and phenotypic drug resistance testing to monitor antiretroviral chemotherapy. Clin. Infect. Dis. 32:774-782.
7. Hanna, G. J., V. A. Johnson, D. R. Kuritzkes, D. D. Richman, J. Martinez-Picado, L, Sutton, J. D. Hazelwood, and R. T. D'Aquila. 2000. Comparison of sequencing by hybridization and cycle sequencing for genotyping of human immunodeficiency virus type 1 reverse transcriptase. J. Clin. Microbiol. 38:2715-2721.
8. Hirsch, M. S., F. Brun-Vezinet, R. T. D'Aquila, S. M. Hammer, V. A. Johnson, D. R. Kuritzkes, C. Loveday, J. W. Mellors, B. Clotet, B. Conway, L. M. Demeter, S. Vella, D. M. Jacobsen, and D. D. Richman. 2000. Antiretroviral drug resistance testing in adult HIV-1 infection: recommendations of an International AIDS Society-USA Panel. JAMA 283:2417-2426.
9. King, R. W., S. Garber, D. L. Winslow, C. Reid, B. L. T., E. Anton, and M. J. Otto. 1995. Multiple mutations in the human immunodeficiency virus protease gene are responsible for decreased susceptibility to protease inhibitors. Antiviral Chem. Chemother. 669:80-88.
10. Parikh, U., C. Calef, B. Larder, R. Schnazi, and J. W. Mellors. 2001. Mutations in retroviral genes associated with drug resistance, p. 191-277. In C. Kuiken, B. Foley, B. Hahn, P. Marx, F. McCutchan, J. W. Mellors, S. Wolinsky, and B. Korber (ed.), HIV sequence compendium 2001. Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos, N.Mex.
11. Romanelli, F., and C. Pomeroy. 2000. Human immunodeficiency virus drug resistance testing: state of the art in genotypic and phenotypic testing of antiretrovirals. Pharmacotherapy 20:151-157.
12. Schuurman, R., L. Demeter, P. Reichelderfer, J. Tijnagel, T. de Groot, and C. Boucher. 1999. Worldwide evaluation of DNA sequencing approaches for identification of drug resistance mutations in the human immunodeficiency virus type 1 reverse transcriptase. J. Clin. Microbiol. 37:2291-2296.
13. Weinstein, M. C., S. J. Goldie, E. Losina, C. J. Cohen, J. D. Baxter, H. Zhang, A. D. Kimmel, and K. A. Freedberg. 2001. Use of genotypic resistance testing to guide hiv therapy: clinical impact and cost-effectiveness. Ann. Intern. Med. 134:440-450.